Only men with prostate tumors of the luminal B subtype benefited from adding apalutamide to salvage radiation in the phase 2 BALANCE trial.

Metastatic prostate cancer is cancer that began in the prostate but has spread to other parts of the body. There's no cure, but there are a number of effective treatments you can discuss with a healthcare provider that may be able to prolong your life and ...

A new study suggests cholesterol-lowering statins, when combined with apalutamide and hormone therapy, can significantly extend survival for men with

Joe Biden’s recent diagnosis of "aggressive" prostate cancer has sparked concerns about how far the disease has advanced. The former president’s prostate cancer has been characterized by a Gleason score of 9 (grade group 5) with "metastasis to the bone.

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery - the first predictive biomarker in this setting.

Dr. Matthew Smith answers the question: 'Hormone Refractory Prostate Cancer?' March 16, 2009 -- Question: What is hormone refractory prostate cancer? Answer: Nearly all men respond to initial treatment with hormone therapy. Accordingly, prostate cancer is ...